OptimizeRx Corp Insider Transaction

Stephen L. Silvestro, Chief Executive Officer of OptimizeRx Corp, reported a disposition of 3,361 shares of Common Stock on December 23, 2025. The shares were sold at a price of $12.74 per share, totaling $42,844.74. This transaction was conducted under a Rule 10b5-1(c) plan adopted on March 11, 2021. Following this disposition, Mr. Silvestro directly owns 190,507 shares of OptimizeRx Corp stock. The filing also notes that some shares were withheld for tax obligations upon vesting of restricted stock units.